Ë®ÒË·» Institute for Translational Neuroscience SITraN is an essential development in the fight against motor neurone disease, other common neurodegenerative disorders, stroke and neuroinflammatory conditions. You are here Home Ë®ÒË·» Institute for Translational Neuroscience Photo of Queen Elizabeth II visiting SITraN in 2010 Ë®ÒË·» SITraN Our impact Our research Study with us Facilities News 10 November 2023 The Duchess of Gloucester explores pioneering Parkinson's research at SITraN Parkinson’s UK Patron, Her Royal Highness The Duchess of Gloucester, met neuroscientists from the University of Ë®ÒË·» who are tackling the root causes of the progressive condition 3 November 2023 New research institute to accelerate the search for a cure for MND The new UK Motor Neuron Disease Research Institute, or UK MND RI, aims to discover new treatments that could ultimately mean MND becomes a curable condition. 26 October 2023 University of Ë®ÒË·» spinout company Crucible Therapeutics raises £5 million to advance pioneering treatments for neurological diseases University of Ë®ÒË·» spinout company, Crucible Therapeutics, a biotechnology company developing novel therapies to treat the most common genetic form of MND and frontotemporal dementia (FTD), has secured £5 million from Northern Gritstone. 29 June 2023 AI tool could speed up dementia diagnosis A new AI tool that could help doctors assess the early signs of dementia and Alzheimer’s more quickly and efficiently, has been developed by researchers at the University of Ë®ÒË·». View all SITraN news
